Mattia Costa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mattia Costa has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Alessandro Ferretti
Pediatrics Unit, Neuroscience, Mental Health and Sense Organs (NESMOS) Department, Faculty of Medicine and Psychology, Sapienza University of Rome, S. Andrea Hospital, Rome, Italy; Scientific Committee of Associazione Bambini Cri Du Chat (ABC), Florence, Italy
2 shared publications - Alice Rubeo
NESMOS Department, Faculty of Medicine & Psychology Sapienza University of Rome c/o Sant'Andrea University Hospital Rome Italy
2 shared publications - Giovanni Di Nardo
Department of Neurosciences, Mental Health and Sensory Organs (NESMOS), Sapienza University of Rome, Rome, Italy
2 shared publications - Marco Bianchi
Department of Neurosciences, Mental Health and Sensory Organs (NESMOS) Sapienza University of Rome Rome Italy
2 shared publications - Pasquale Parisi
Department of Neuroscience, Mental Health, and Sensory Organs (NESMOS Department) Sapienza University of Rome Rome Italy
2 shared publications - Alessandro Bozzao
Neuroradiology Unit, Sant'Andrea Hospital, Department of Neuroscience, Mental Health and Sense Organs (NESMOS) Sapienza University of Rome Rome Italy
1 shared publication
Latest Publications
Immediate Postpartum Mental Health and Sleep in Mothers and Fathers with Healthy Newborns
Background: The postpartum period represents a critical window for parental psychological adjustment, but whether this is the case immediately after birth remains understudied. Furthermore, while many aspects of maternal mental health have been widely investigated in high‐risk contexts, less is known about critical factors such as sleep‐related vulnerability and attachment‐related processes in low‐risk situations, how these relate to early mental health in fathers, or how these factors may be associated with neonatal behavior. Methods: Thirty‐two mother–father–newborn triads, comprising 32 mothers, 32 fathers, and their 32 healthy, full‐term newborns, were included in the study. Newborn behavioral functioning was evaluated with the NBAS on Day 2. Mothers completed the EPDS, ECR, and STAI on Day 3. Both parents completed the CES‐D, PSS, SCI, and FIRST on Day 3. Correlation, paired‐comparison, and exploratory regression analyses were conducted. Results: Clinically relevant elevations on at least one psychological or sleep‐related measure were observed in 59.4% of mothers and 28.1% of fathers. Mothers showed significantly higher depressive symptoms, poorer sleep quality, and greater sleep reactivity than fathers. Among mothers, depressive symptoms were associated with greater sleep reactivity, with trait anxiety showing the strongest association with depressive symptoms. Maternal and paternal depressive symptoms were also positively associated across partners. Newborn behavioral functioning was broadly within expected ranges, and no association between parental psychological or sleep‐related measures and NBAS cluster scores survived FDR correction. Discussion: Psychological and sleep‐related vulnerability was detectable in parents during the immediate postpartum period in this low‐risk clinical context, with higher levels observed in mothers. Cross‐partner concordance was limited to depressive symptoms. These findings suggest that early screening of both parents may be clinically relevant. Sleep reactivity and anxiety were associated with maternal postpartum distress, but their potential predictive value requires confirmation in longitudinal studies.
Immediate Postpartum Mental Health and Sleep in Mothers and Fathers with Healthy Newborns
Background: The postpartum period represents a critical window for parental psychological adjustment, but whether this is the case immediately after birth remains understudied. Furthermore, while many aspects of maternal mental health have been widely investigated in high‐risk contexts, less is known about critical factors such as sleep‐related vulnerability and attachment‐related processes in low‐risk situations, how these relate to early mental health in fathers, or how these factors may be associated with neonatal behavior. Methods: Thirty‐two mother–father–newborn triads, comprising 32 mothers, 32 fathers, and their 32 healthy, full‐term newborns, were included in the study. Newborn behavioral functioning was evaluated with the NBAS on Day 2. Mothers completed the EPDS, ECR, and STAI on Day 3. Both parents completed the CES‐D, PSS, SCI, and FIRST on Day 3. Correlation, paired‐comparison, and exploratory regression analyses were conducted. Results: Clinically relevant elevations on at least one psychological or sleep‐related measure were observed in 59.4% of mothers and 28.1% of fathers. Mothers showed significantly higher depressive symptoms, poorer sleep quality, and greater sleep reactivity than fathers. Among mothers, depressive symptoms were associated with greater sleep reactivity, with trait anxiety showing the strongest association with depressive symptoms. Maternal and paternal depressive symptoms were also positively associated across partners. Newborn behavioral functioning was broadly within expected ranges, and no association between parental psychological or sleep‐related measures and NBAS cluster scores survived FDR correction. Discussion: Psychological and sleep‐related vulnerability was detectable in parents during the immediate postpartum period in this low‐risk clinical context, with higher levels observed in mothers. Cross‐partner concordance was limited to depressive symptoms. These findings suggest that early screening of both parents may be clinically relevant. Sleep reactivity and anxiety were associated with maternal postpartum distress, but their potential predictive value requires confirmation in longitudinal studies.
- Open Access
Pediatric Antimicrobial Stewardship: Current Evidence and Emerging Challenges
Antimicrobial resistance (AMR) is a growing global health threat with important implications for pediatric populations. Children are frequently exposed to antibiotics in both hospital and community settings, where inappropriate prescribing, suboptimal dosing, and excessive use of broad-spectrum agents remain common. These practices contribute to the emergence of resistant pathogens, increase adverse drug events, and may negatively affect the developing immune system and microbiota. This narrative review summarizes current evidence on pediatric antimicrobial stewardship (AMS), highlighting recent trends in antimicrobial use and key stewardship strategies across inpatient and outpatient care. Core interventions, including prospective audit and feedback, preauthorization, guideline implementation, AWaRe-based prescribing, therapeutic drug monitoring, and early intravenous-to-oral switch, are discussed. The review also examines the expanding role of diagnostic stewardship, focusing on rapid molecular diagnostics, point-of-care testing, and host-response biomarkers to improve differentiation between bacterial and viral infections and support targeted therapy. Despite progress, pediatric AMS faces persistent challenges, such as regional variability in prescribing practices, limited pediatric-specific data for new antimicrobials and diagnostics, and organizational and behavioral barriers. Emerging tools, particularly artificial intelligence, may enhance decision-making and optimize antimicrobial use, although further validation in pediatric settings is needed. Strengthening pediatric AMS is essential to improving care quality and mitigating the impact of AMR.
Open AccessPediatric Antimicrobial Stewardship: Current Evidence and Emerging Challenges
Antimicrobial resistance (AMR) is a growing global health threat with important implications for pediatric populations. Children are frequently exposed to antibiotics in both hospital and community settings, where inappropriate prescribing, suboptimal dosing, and excessive use of broad-spectrum agents remain common. These practices contribute to the emergence of resistant pathogens, increase adverse drug events, and may negatively affect the developing immune system and microbiota. This narrative review summarizes current evidence on pediatric antimicrobial stewardship (AMS), highlighting recent trends in antimicrobial use and key stewardship strategies across inpatient and outpatient care. Core interventions, including prospective audit and feedback, preauthorization, guideline implementation, AWaRe-based prescribing, therapeutic drug monitoring, and early intravenous-to-oral switch, are discussed. The review also examines the expanding role of diagnostic stewardship, focusing on rapid molecular diagnostics, point-of-care testing, and host-response biomarkers to improve differentiation between bacterial and viral infections and support targeted therapy. Despite progress, pediatric AMS faces persistent challenges, such as regional variability in prescribing practices, limited pediatric-specific data for new antimicrobials and diagnostics, and organizational and behavioral barriers. Emerging tools, particularly artificial intelligence, may enhance decision-making and optimize antimicrobial use, although further validation in pediatric settings is needed. Strengthening pediatric AMS is essential to improving care quality and mitigating the impact of AMR.
- 4 March 2026
- Published by SAGE Publications in Journal of Child Neurology
Managing Fever and Vaccination Risks in Dravet Syndrome: From Pathophysiology to Clinical Practice
Dravet syndrome (DS), a severe developmental and epileptic encephalopathy often linked to SCN1A mutations, is defined by a profound thermosensitivity, making fever and hyperthermia potent seizure triggers. This review synthesizes evidence-based strategies and expert consensus for the management of fever and vaccination in children with DS. Management diverges from standard pediatrics, prioritizing aggressive pyrexia control through early antipyretics, physical cooling, and prophylactic benzodiazepines. Proactive strategies are also crucial for non-febrile hyperthermia from triggers like hot baths and overexertion. Although vaccinations can precipitate an initial seizure, they neither cause DS nor worsen its prognosis. Immunization remains strongly recommended, with prophylactic antipyretics advised as a key risk-mitigation measure. Importantly, current management strategies are based primarily on expert consensus rather than controlled clinical trials. Bridging expert consensus with clinical evidence is essential to reduce morbidity and improve long-term quality of life in DS.
- 4 March 2026
- Published by SAGE Publications in Journal of Child Neurology
Managing Fever and Vaccination Risks in Dravet Syndrome: From Pathophysiology to Clinical Practice
Dravet syndrome (DS), a severe developmental and epileptic encephalopathy often linked to SCN1A mutations, is defined by a profound thermosensitivity, making fever and hyperthermia potent seizure triggers. This review synthesizes evidence-based strategies and expert consensus for the management of fever and vaccination in children with DS. Management diverges from standard pediatrics, prioritizing aggressive pyrexia control through early antipyretics, physical cooling, and prophylactic benzodiazepines. Proactive strategies are also crucial for non-febrile hyperthermia from triggers like hot baths and overexertion. Although vaccinations can precipitate an initial seizure, they neither cause DS nor worsen its prognosis. Immunization remains strongly recommended, with prophylactic antipyretics advised as a key risk-mitigation measure. Importantly, current management strategies are based primarily on expert consensus rather than controlled clinical trials. Bridging expert consensus with clinical evidence is essential to reduce morbidity and improve long-term quality of life in DS.